Morales Mallory

Chief Accounting OfficerImmuneering Corp (IMRX) · full profile →Form 4 · filed May 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 21, 2024Disposed to issuer(D)10K$00
May 21, 2024Grant(A)10K$010K
May 21, 2024Disposed to issuer(D)24K$00
May 21, 2024Grant(A)24K$024K
May 21, 2024Disposed to issuer(D)5K$00
May 21, 2024Grant(A)72K$072K
May 21, 2024Disposed to issuer(D)15K$00
May 21, 2024Grant(A)15K$015K
May 21, 2024Disposed to issuer(D)61K$00
May 21, 2024Grant(A)61K$061K
May 21, 2024Disposed to issuer(D)72K$00
May 21, 2024Grant(A)5K$05K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-024950) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about IMRX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001628280-24-024950"
Ask your agent
Use Arkolith to summarize insider buying and selling at Immuneering Corp
over the last 90 days and cite the filings.